Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.31 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.36.
Market Cap
8.31T
Revenue
4.52T
Profits
205.98B
PE Ratio
40.36
Profit Margin
4.56%
Dividend Yield
0.44%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 854.12B | 3.78% | 6,270,060 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 587.99B | -0.13% | 6,313,767 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 380.25B | -1.15% | 5,702,608 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 310.33B | 1.78% | 2,158,245 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 298.76B | 0.46% | 6,351,136 | 65.01B |
| 6 | NVS | Novartis AG | 295.40B | 1.53% | 1,626,741 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 248.69B | 1.25% | 5,472,933 | 447.57B |
| 8 | AMGN | Amgen Inc. | 190.44B | 0.41% | 2,726,198 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 183.71B | 0.61% | 1,504,904 | 44.56B |
| 10 | ABT | Abbott Laboratories | 178.31B | -0.28% | 7,450,953 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 174.14B | 0.67% | 5,286,155 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 164.96B | 0.75% | 1,427,023 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 163.38B | -0.73% | 24,087,259 | 48.59B |
| 14 | PFE | Pfizer Inc. | 162.40B | 1.67% | 44,205,788 | 62.58B |
| 15 | DHR | Danaher Corporation | 135.02B | 0.63% | 3,780,461 | 24.57B |
| 16 | SYK | Stryker Corporation | 126.06B | 0.25% | 1,657,096 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 126.04B | 1.78% | 9,880,782 | 48.19B |
| 18 | SNY | Sanofi | 116.20B | -0.93% | 2,592,665 | 54.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 113.62B | 0.16% | 1,188,409 | 12.00B |
| 20 | GSK | GSK plc | 112.19B | 1.45% | 6,253,812 | 43.97B |
| 21 | MDT | Medtronic plc | 110.49B | -0.68% | 7,407,500 | 35.48B |
| 22 | MCK | McKesson Corporation | 106.85B | 0.80% | 729,550 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 106.14B | 0.32% | 699,490 | 75.60B |
| 24 | CVS | CVS Health Corporation | 92.22B | 0.93% | 5,099,029 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 92.14B | -1.20% | 19,485,143 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.76B | 0.60% | 627,150 | 14.34B |
| 27 | CI | The Cigna Group | 70.48B | 0.21% | 1,157,943 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 65.57B | 1.96% | 1,310,575 | 199.13B |
| 29 | COR | Cencora, Inc. | 61.79B | 1.12% | 1,532,519 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 58.64B | 1.35% | 4,075,826 | 28.48B |
| 31 | MDLN | Medline Inc. | 57.80B | -1.12% | 11,643,508 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 49.89B | 0.58% | 1,462,851 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.51B | -0.78% | 2,211,521 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.85B | 1.47% | 5,356,866 | 6.07B |
| 35 | ARGX | argenx SE | 46.54B | 1.76% | 365,175 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.96B | 0.49% | 490,008 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.52B | -0.57% | 2,459,305 | 21.92B |
| 38 | HLN | Haleon plc | 44.14B | -0.40% | 7,667,346 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.60B | -0.65% | 672,944 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.89B | 0.21% | 1,725,480 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.54B | 0.82% | 2,850,929 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 35.23B | 0.43% | 4,578,165 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 34.20B | 3.86% | 343,204 | 5.34B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 32.84B | 1.12% | 3,350,885 | 20.63B |
| 45 | A | Agilent Technologies, Inc. | 32.37B | 0.49% | 1,555,155 | 7.07B |
| 46 | RMD | ResMed Inc. | 32.32B | -0.73% | 1,051,425 | 5.40B |
| 47 | WAT | Waters Corporation | 29.42B | 0.70% | 911,908 | 3.17B |
| 48 | IQV | IQVIA Holdings Inc. | 28.94B | 1.09% | 770,073 | 16.31B |
| 49 | NTRA | Natera, Inc. | 28.80B | 1.61% | 1,293,899 | 2.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.21B | -1.66% | 1,451,544 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 27.97B | 1.08% | 3,834,451 | 2.38B |
| 52 | BIIB | Biogen Inc. | 26.97B | 0.25% | 1,389,506 | 9.89B |
| 53 | PHG | Koninklijke Philips N.V. | 26.07B | -0.40% | 862,885 | 20.94B |
| 54 | MTD | Mettler-Toledo International Inc. | 25.80B | 1.02% | 173,808 | 4.03B |
| 55 | UTHR | United Therapeutics Corporation | 24.99B | -3.83% | 754,931 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 24.00B | -0.68% | 3,530,221 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 22.47B | 2.22% | 715,364 | 13.95B |
| 58 | DGX | Quest Diagnostics Incorporated | 21.72B | 0.87% | 587,379 | 11.04B |
| 59 | STE | STERIS plc | 21.57B | -0.54% | 659,049 | 5.83B |
| 60 | BNTX | BioNTech SE | 21.46B | 0.61% | 617,266 | 3.37B |
| 61 | HUM | Humana Inc. | 21.24B | 2.05% | 1,528,982 | 129.66B |
| 62 | ROIV | Roivant Sciences Ltd. | 19.93B | 0.51% | 7,120,478 | 13.31M |
| 63 | MRNA | Moderna, Inc. | 19.84B | -1.52% | 7,602,579 | 1.94B |
| 64 | RVMD | Revolution Medicines, Inc. | 19.55B | 1.43% | 2,183,808 | - |
| 65 | ILMN | Illumina, Inc. | 19.36B | 2.73% | 1,223,848 | 4.34B |
| 66 | INCY | Incyte Corporation | 18.77B | 0.19% | 1,479,390 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.20B | 0.84% | 1,094,786 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.81B | 0.67% | 2,497,783 | 8.23B |
| 69 | HOLX | Hologic, Inc. | 16.88B | 0.01% | 2,309,114 | 4.13B |
| 70 | GMAB | Genmab A/S | 16.77B | 1.45% | 681,231 | 3.72B |
| 71 | CNC | Centene Corporation | 16.70B | 3.70% | 5,278,365 | 176.15B |
| 72 | RGC | Regencell Bioscience Holdings Limited | 16.67B | 32.60% | 1,199,126 | - |
| 73 | THC | Tenet Healthcare Corporation | 16.55B | 0.83% | 818,173 | 21.31B |
| 74 | VTRS | Viatris Inc. | 15.69B | 0.89% | 9,601,190 | 14.30B |
| 75 | SMMT | Summit Therapeutics Inc. | 14.67B | -0.21% | 2,374,602 | - |
| 76 | PODD | Insulet Corporation | 14.57B | -1.33% | 1,169,676 | 2.71B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 14.43B | 0.26% | 2,254,108 | 502.08M |
| 78 | ASND | Ascendis Pharma A/S | 14.01B | -0.21% | 484,541 | 845.52M |
| 79 | COO | The Cooper Companies, Inc. | 13.94B | -0.10% | 1,763,595 | 4.15B |
| 80 | MEDP | Medpace Holdings, Inc. | 13.89B | 1.93% | 255,857 | 2.53B |
| 81 | SNN | Smith & Nephew plc | 13.58B | 0.98% | 593,733 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.30B | 0.62% | 1,132,205 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.91B | 0.18% | 566,561 | 1.40B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.41B | 0.05% | 1,663,675 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 12.31B | 0.76% | 871,879 | 4.03B |
| 86 | FMS | Fresenius Medical Care AG | 12.16B | -0.93% | 495,079 | 23.05B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.15B | 1.22% | 422,783 | 958.40M |
| 88 | GH | Guardant Health, Inc. | 11.96B | -1.32% | 1,655,434 | 982.02M |
| 89 | GMED | Globus Medical, Inc. | 11.87B | 1.83% | 1,348,543 | 2.94B |
| 90 | JAZZ | Jazz Pharmaceuticals plc | 11.59B | -0.41% | 687,010 | 4.27B |
| 91 | ENSG | The Ensign Group, Inc. | 11.54B | -0.69% | 442,888 | 5.06B |
| 92 | ELAN | Elanco Animal Health Incorporated | 11.49B | -3.38% | 4,866,058 | 4.72B |
| 93 | EXEL | Exelixis, Inc. | 11.44B | 2.68% | 1,872,053 | 2.32B |
| 94 | SOLV | Solventum Corporation | 11.16B | -1.45% | 1,517,953 | 8.33B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.01B | 1.33% | 2,229,692 | 3.22B |
| 96 | UHS | Universal Health Services, Inc. | 10.87B | -0.58% | 743,479 | 17.36B |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 10.80B | -2.74% | 2,843,331 | 3.85B |
| 98 | DVA | DaVita Inc. | 10.04B | -2.18% | 978,180 | 13.64B |
| 99 | RVTY | Revvity, Inc. | 9.83B | 0.35% | 693,504 | 2.86B |
| 100 | EHC | Encompass Health Corporation | 9.68B | 0.87% | 805,456 | 5.94B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.38B | 3.25% | 1,091,386 | 5.37M |
| 102 | MASI | Masimo Corporation | 9.29B | 0.08% | 771,266 | 1.53B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 8.89B | -0.90% | 439,003 | 7.46M |
| 104 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.81B | 0.35% | 1,676,172 | 1.09B |
| 105 | AXSM | Axsome Therapeutics, Inc. | 8.79B | 1.63% | 604,031 | 638.50M |
| 106 | BAX | Baxter International Inc. | 8.66B | -0.12% | 8,409,007 | 11.24B |
| 107 | CRL | Charles River Laboratories International, Inc. | 8.61B | 1.39% | 915,701 | 4.02B |
| 108 | BTSG | BrightSpring Health Services, Inc. | 8.58B | -1.36% | 2,611,070 | 12.91B |
| 109 | ICLR | ICON Public Limited Company | 8.51B | 0.69% | 798,185 | 8.10B |
| 110 | PCVX | Vaxcyte, Inc. | 8.42B | 0.69% | 2,689,991 | - |
| 111 | TEM | Tempus AI, Inc. | 8.41B | 4.00% | 5,619,854 | 1.27B |
| 112 | HSIC | Henry Schein, Inc. | 8.38B | -0.90% | 1,149,063 | 13.18B |
| 113 | TECH | Bio-Techne Corporation | 8.37B | 2.33% | 2,458,558 | 1.22B |
| 114 | QGEN | Qiagen N.V. | 8.32B | 0.85% | 1,126,715 | 2.09B |
| 115 | NUVL | Nuvalent, Inc. | 8.31B | 3.11% | 1,006,617 | - |
| 116 | CYTK | Cytokinetics, Incorporated | 8.20B | 1.06% | 2,365,114 | 88.04M |
| 117 | ATR | AptarGroup, Inc. | 8.08B | 0.58% | 380,192 | 3.78B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.75B | 1.19% | 1,760,998 | 1.40B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.57B | 0.23% | 350,882 | 389.13M |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.51B | -0.14% | 176,901 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.37B | -6.91% | 19,382,477 | 113.29M |
| 122 | MOH | Molina Healthcare, Inc. | 7.08B | 1.89% | 1,057,888 | 43.56B |
| 123 | HQY | HealthEquity, Inc. | 7.04B | -0.23% | 926,053 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.93B | 1.97% | 667,357 | 39.21M |
| 125 | ACLX | Arcellx, Inc. | 6.73B | -0.06% | 960,866 | 22.29M |
| 126 | GRFS | Grifols, S.A. | 6.67B | 2.87% | 806,622 | 8.83B |
| 127 | RGEN | Repligen Corporation | 6.67B | 0.42% | 1,115,095 | 738.26M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | -1.64% | 583,084 | 46.02M |
| 129 | BLTE | Belite Bio, Inc | 6.58B | 4.90% | 161,162 | - |
| 130 | GKOS | Glaukos Corporation | 6.54B | 4.63% | 1,000,389 | 507.44M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.22B | 0.08% | 692,924 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.16B | 0.35% | 11,441,825 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.13% | 8,359,326 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.02B | 1.32% | 945,363 | 189.76M |
| 135 | BLCO | Bausch + Lomb Corporation | 5.91B | 4.91% | 753,666 | 5.10B |
| 136 | ALKS | Alkermes plc | 5.83B | -0.88% | 4,766,176 | 1.48B |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | 2.42% | 873,315 | 521.31M |
| 138 | PTCT | PTC Therapeutics, Inc. | 5.69B | 0.91% | 1,043,690 | 1.73B |
| 139 | COGT | Cogent Biosciences, Inc. | 5.68B | -8.44% | 8,616,848 | - |
| 140 | SRRK | Scholar Rock Holding Corporation | 5.67B | 0.39% | 2,633,262 | - |
| 141 | CGON | CG Oncology, Inc. | 5.64B | -1.32% | 1,160,284 | 4.04M |
| 142 | BRKR | Bruker Corporation | 5.49B | -0.11% | 2,591,068 | 3.44B |
| 143 | CELC | Celcuity Inc. | 5.46B | -1.06% | 736,578 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -2.51% | 1,379,772 | 7.50M |
| 145 | CAI | Caris Life Sciences, Inc. | 5.41B | 6.99% | 2,408,729 | 812.03M |
| 146 | AVTR | Avantor, Inc. | 5.25B | -0.89% | 7,916,362 | 6.55B |
| 147 | TFX | Teleflex Incorporated | 5.23B | -0.99% | 596,823 | 1.99B |
| 148 | CHE | Chemed Corporation | 5.20B | -0.05% | 177,063 | 2.53B |
| 149 | APLS | Apellis Pharmaceuticals, Inc. | 5.16B | 0.40% | 30,394,890 | 1.00B |
| 150 | ERAS | Erasca, Inc. | 5.16B | 2.60% | 5,241,368 | - |
| 151 | IMVT | Immunovant, Inc. | 5.11B | 1.05% | 699,413 | - |
| 152 | PACS | PACS Group, Inc. | 4.98B | -1.40% | 577,399 | 5.29B |
| 153 | TGTX | TG Therapeutics, Inc. | 4.96B | 1.08% | 1,829,117 | 616.29M |
| 154 | LNTH | Lantheus Holdings, Inc. | 4.92B | -0.20% | 701,596 | 1.54B |
| 155 | CRSP | CRISPR Therapeutics AG | 4.69B | 2.61% | 1,310,054 | 3.51M |
| 156 | WAY | Waystar Holding Corp. | 4.56B | -1.41% | 1,818,399 | 1.10B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.53B | -0.14% | 4,090,435 | 634.21M |
| 158 | HIMS | Hims & Hers Health, Inc. | 4.52B | -4.43% | 26,622,422 | 2.35B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.48B | 0.76% | 1,103,211 | 2.04M |
| 160 | CORT | Corcept Therapeutics Incorporated | 4.47B | 4.14% | 1,944,994 | 761.41M |
| 161 | RDNT | RadNet, Inc. | 4.29B | -1.04% | 870,222 | 2.04B |
| 162 | NVST | Envista Holdings Corporation | 4.24B | 2.09% | 2,735,148 | 2.72B |
| 163 | DOCS | Doximity, Inc. | 4.24B | -1.59% | 3,612,288 | 637.78M |
| 164 | SHC | Sotera Health Company | 4.23B | 3.70% | 4,249,846 | 1.16B |
| 165 | OPCH | Option Care Health, Inc. | 4.14B | -1.60% | 2,292,989 | 5.65B |
| 166 | MMED | Minimed Group, Inc. | 4.07B | -2.95% | 990,797 | 2.89B |
| 167 | MMSI | Merit Medical Systems, Inc. | 4.06B | -1.02% | 794,954 | 1.52B |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 4.05B | 2.25% | 1,808,836 | 3.02B |
| 169 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | -0.02% | 261,868 | 268.09M |
| 170 | SYRE | Spyre Therapeutics, Inc. | 3.84B | -3.05% | 890,620 | - |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.83B | 0.69% | 1,099,690 | 7.70M |
| 172 | IRTC | iRhythm Holdings, Inc. | 3.82B | 0.17% | 585,156 | 747.14M |
| 173 | BLLN | BillionToOne, Inc. | 3.81B | 5.09% | 611,364 | 305.11M |
| 174 | VKTX | Viking Therapeutics, Inc. | 3.81B | 1.29% | 2,240,678 | - |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 0.27% | 1,612,706 | 1.07B |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.77B | 2.50% | 994,135 | 22.50M |
| 177 | STVN | Stevanato Group S.p.A. | 3.75B | - | 1,070,847 | 1.39B |
| 178 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.68B | -0.01% | 494,012 | 677.56M |
| 179 | ALHC | Alignment Healthcare, Inc. | 3.65B | 1.31% | 3,633,171 | 3.95B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 3.55B | 5.21% | 1,593,569 | - |
| 181 | GPCR | Structure Therapeutics Inc. | 3.55B | 4.09% | 1,356,813 | - |
| 182 | LIVN | LivaNova PLC | 3.53B | 1.68% | 637,967 | 1.39B |
| 183 | LEGN | Legend Biotech Corporation | 3.52B | 5.31% | 1,073,741 | 1.03B |
| 184 | OSCR | Oscar Health, Inc. | 3.49B | 2.27% | 4,421,078 | 11.70B |
| 185 | TMDX | TransMedics Group, Inc. | 3.44B | 1.00% | 792,569 | 605.49M |
| 186 | LQDA | Liquidia Corporation | 3.30B | -0.72% | 1,348,208 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.30B | 1.32% | 3,370,019 | 3.05B |
| 188 | ICUI | ICU Medical, Inc. | 3.13B | -3.04% | 250,320 | 2.23B |
| 189 | DNLI | Denali Therapeutics Inc. | 3.12B | 2.50% | 1,912,319 | - |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.10B | -3.45% | 176,333 | 803.79M |
| 191 | TWST | Twist Bioscience Corporation | 3.04B | 4.25% | 1,261,877 | 391.56M |
| 192 | HNGE | Hinge Health, Inc. | 3.03B | -0.18% | 492,225 | 587.86M |
| 193 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | 0.24% | 1,446,380 | 588.99M |
| 194 | TNGX | Tango Therapeutics, Inc. | 3.03B | 1.43% | 2,561,080 | 62.38M |
| 195 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | 2.29% | 1,348,861 | 376.07M |
| 196 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | 0.10% | 350,671 | 451.36M |
| 197 | DYN | Dyne Therapeutics, Inc. | 2.99B | -0.17% | 1,430,711 | - |
| 198 | ITGR | Integer Holdings Corporation | 2.97B | -1.77% | 494,960 | 1.85B |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.96B | -0.48% | 624,449 | 718.95M |
| 200 | TVTX | Travere Therapeutics, Inc. | 2.90B | 5.76% | 2,277,456 | 490.73M |
| 201 | ALMS | Alumis Inc. | 2.89B | 3.18% | 1,610,776 | 24.05M |
| 202 | VERA | Vera Therapeutics, Inc. | 2.89B | 0.67% | 1,617,984 | - |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.85B | -2.52% | 813,476 | 218.71M |
| 204 | TXG | 10x Genomics, Inc. | 2.82B | 3.86% | 2,427,762 | 642.82M |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.74B | 1.11% | 1,478,498 | 247.00M |
| 206 | PBH | Prestige Consumer Healthcare Inc. | 2.73B | -2.68% | 538,540 | 1.10B |
| 207 | CON | Concentra Group Holdings Parent, Inc. | 2.73B | -1.03% | 537,262 | 2.16B |
| 208 | KOD | Kodiak Sciences Inc. | 2.64B | 12.30% | 2,621,070 | - |
| 209 | WRBY | Warby Parker Inc. | 2.62B | 1.61% | 2,232,935 | 871.91M |
| 210 | HAE | Haemonetics Corporation | 2.61B | -0.21% | 358,686 | 1.32B |
| 211 | PRVA | Privia Health Group, Inc. | 2.61B | 2.43% | 883,001 | 2.12B |
| 212 | VCYT | Veracyte, Inc. | 2.57B | 0.59% | 637,988 | 517.15M |
| 213 | HCM | HUTCHMED (China) Limited | 2.54B | 3.54% | 56,839 | 548.51M |
| 214 | IMNM | Immunome, Inc. | 2.54B | 2.65% | 1,148,116 | 6.94M |
| 215 | ORKA | Oruka Therapeutics, Inc. | 2.50B | 2.81% | 1,013,469 | - |
| 216 | LFST | LifeStance Health Group, Inc. | 2.48B | - | 2,040,780 | 1.42B |
| 217 | LMAT | LeMaitre Vascular, Inc. | 2.48B | -0.38% | 234,652 | 249.60M |
| 218 | IRON | Disc Medicine, Inc. | 2.47B | 1.31% | 948,428 | - |
| 219 | NHC | National HealthCare Corporation | 2.46B | -1.08% | 120,083 | 1.52B |
| 220 | AAPG | Ascentage Pharma Group International | 2.44B | 10.10% | 8,181 | 82.08M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.41B | 1.64% | 2,092,320 | 139.74M |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | -0.11% | 775,489 | 1.45B |
| 223 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.35B | -1.47% | 4,907,188 | 874.84M |
| 224 | XRAY | DENTSPLY SIRONA Inc. | 2.33B | 0.52% | 3,262,495 | 3.68B |
| 225 | SRPT | Sarepta Therapeutics, Inc. | 2.32B | 1.70% | 2,074,580 | 2.20B |
| 226 | ZLAB | Zai Lab Limited | 2.29B | 8.13% | 1,245,794 | 460.16M |
| 227 | ELVN | Enliven Therapeutics, Inc. | 2.26B | -3.60% | 840,993 | - |
| 228 | ADPT | Adaptive Biotechnologies Corporation | 2.22B | 3.96% | 2,485,642 | 276.98M |
| 229 | PAHC | Phibro Animal Health Corporation | 2.22B | -0.99% | 377,291 | 1.46B |
| 230 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.09% | 971,207 | 158.18M |
| 231 | GRAL | GRAIL, Inc. | 2.20B | 3.72% | 659,038 | 147.17M |
| 232 | MANE | Veradermics, Incorporated | 2.19B | -6.92% | 625,551 | - |
| 233 | ACHC | Acadia Healthcare Company, Inc. | 2.18B | 1.20% | 2,772,167 | 3.31B |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.18B | -2.51% | 1,068,928 | - |
| 235 | NKTR | Nektar Therapeutics | 2.17B | 5.23% | 1,301,630 | 55.23M |
| 236 | ADMA | ADMA Biologics, Inc. | 2.17B | 1.11% | 7,793,862 | 510.17M |
| 237 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | 2.23% | 2,275,889 | 172.35M |
| 238 | RARE | Ultragenyx Pharmaceutical Inc. | 2.10B | 2.24% | 2,310,380 | 673.00M |
| 239 | HTFL | HeartFlow, Inc. | 2.10B | 0.70% | 1,946,726 | 176.03M |
| 240 | CLDX | Celldex Therapeutics, Inc. | 2.08B | -1.45% | 432,960 | 1.55M |
| 241 | BHC | Bausch Health Companies Inc. | 2.07B | 3.33% | 1,339,133 | 10.27B |
| 242 | TYRA | Tyra Biosciences, Inc. | 2.06B | -0.05% | 826,083 | - |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 4.39% | 1,492,530 | 283.06M |
| 244 | DFTX | Definium Therapeutics, Inc. | 2.05B | 8.99% | 3,219,177 | - |
| 245 | NEOG | Neogen Corporation | 2.04B | 1.08% | 2,050,760 | 880.32M |
| 246 | MESO | Mesoblast Limited | 2.03B | 2.73% | 464,854 | 65.38M |
| 247 | SEM | Select Medical Holdings Corporation | 2.02B | - | 1,551,767 | 5.45B |
| 248 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | 1.06% | 1,556,073 | 54.03M |
| 249 | GLPG | Galapagos NV | 1.98B | -0.80% | 348,320 | 1.31B |
| 250 | VRDN | Viridian Therapeutics, Inc. | 1.96B | -2.10% | 2,859,792 | 70.85M |
| 251 | AHG | Akso Health Group | 1.94B | -0.44% | 167,084 | 14.84M |
| 252 | RLAY | Relay Therapeutics, Inc. | 1.92B | 8.24% | 2,400,519 | 15.36M |
| 253 | WGS | GeneDx Holdings Corp. | 1.92B | 2.02% | 736,493 | 427.54M |
| 254 | ZYME | Zymeworks Inc. | 1.91B | 3.59% | 1,136,109 | 105.97M |
| 255 | PHVS | Pharvaris N.V. | 1.91B | 4.25% | 502,006 | - |
| 256 | SLNO | Soleno Therapeutics, Inc. | 1.91B | 10.48% | 2,924,580 | 190.41M |
| 257 | STOK | Stoke Therapeutics, Inc. | 1.89B | -1.75% | 686,238 | 184.42M |
| 258 | SION | Sionna Therapeutics, Inc. | 1.86B | 3.02% | 516,346 | - |
| 259 | OCUL | Ocular Therapeutix, Inc. | 1.81B | -1.65% | 3,349,048 | 51.95M |
| 260 | AXGN | Axogen, Inc. | 1.74B | 1.36% | 1,281,522 | 225.21M |
| 261 | INVA | Innoviva, Inc. | 1.73B | 0.47% | 617,939 | 411.33M |
| 262 | CAPR | Capricor Therapeutics, Inc. | 1.73B | -0.92% | 1,860,028 | 11.13M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 1.72B | -3.43% | 358,319 | - |
| 264 | ESTA | Establishment Labs Holdings Inc. | 1.72B | 3.38% | 468,096 | 211.08M |
| 265 | ATEC | Alphatec Holdings, Inc. | 1.70B | 3.49% | 4,069,685 | 764.16M |
| 266 | ADUS | Addus HomeCare Corporation | 1.70B | 0.21% | 245,975 | 1.42B |
| 267 | GENB | Generate Biomedicines, Inc. | 1.70B | 6.48% | 389,383 | 31.89M |
| 268 | MD | Pediatrix Medical Group, Inc. | 1.68B | -3.23% | 762,167 | 1.91B |
| 269 | VCEL | Vericel Corporation | 1.66B | 1.21% | 647,317 | 276.26M |
| 270 | AORT | Artivion, Inc. | 1.64B | -6.72% | 819,173 | 441.33M |
| 271 | ANAB | AnaptysBio, Inc. | 1.63B | 2.29% | 1,209,061 | 234.60M |
| 272 | NBTX | Nanobiotix S.A. | 1.63B | 10.37% | 128,619 | 11.93M |
| 273 | HRMY | Harmony Biosciences Holdings, Inc. | 1.62B | -0.18% | 692,240 | 868.45M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | -0.33% | 10,858,247 | 74.68M |
| 275 | AHCO | AdaptHealth Corp. | 1.61B | -0.34% | 1,095,491 | 3.24B |
| 276 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -0.13% | 908,749 | 83.98M |
| 277 | OCS | Oculis Holding AG | 1.60B | 1.65% | 353,974 | 1.51M |
| 278 | OGN | Organon & Co. | 1.60B | 2.50% | 4,465,661 | 6.22B |
| 279 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.59B | 3.24% | 834,437 | -665.00K |
| 280 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -1.22% | 455,801 | 883.37M |
| 281 | SGRY | Surgery Partners, Inc. | 1.57B | 2.85% | 1,928,249 | 3.31B |
| 282 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 3.51% | 3,025,559 | 67.67M |
| 283 | PLSE | Pulse Biosciences, Inc. | 1.57B | 6.67% | 267,322 | 350.00K |
| 284 | NUVB | Nuvation Bio Inc. | 1.55B | 5.13% | 3,056,670 | 62.90M |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.54B | 3.99% | 1,555,927 | 911.98M |
| 286 | OMCL | Omnicell, Inc. | 1.54B | 1.68% | 303,397 | 1.18B |
| 287 | IMCR | Immunocore Holdings plc | 1.54B | 0.53% | 437,029 | 400.02M |
| 288 | MBX | MBX Biosciences, Inc. | 1.53B | 8.17% | 405,401 | - |
| 289 | PRGO | Perrigo Company plc | 1.51B | 2.42% | 5,888,248 | 4.25B |
| 290 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.21% | 287,809 | - |
| 291 | DMRA | Damora Therapeutics, Inc. | 1.51B | -3.17% | 166,262 | - |
| 292 | SNDA | Sonida Senior Living, Inc. | 1.50B | -0.47% | 505,648 | 336.39M |
| 293 | ARDX | Ardelyx, Inc. | 1.50B | 2.00% | 6,441,456 | 407.32M |
| 294 | UFPT | UFP Technologies, Inc. | 1.50B | 0.20% | 180,391 | 602.80M |
| 295 | TRVI | Trevi Therapeutics, Inc. | 1.49B | -2.93% | 1,419,781 | - |
| 296 | BHVN | Biohaven Ltd. | 1.45B | 13.71% | 3,496,309 | - |
| 297 | MAZE | Maze Therapeutics, Inc. | 1.44B | -2.68% | 933,965 | 2.50M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.44B | 0.67% | 2,085,595 | 68.56M |
| 299 | PRCT | PROCEPT BioRobotics Corporation | 1.43B | 1.40% | 1,142,886 | 308.05M |
| 300 | IOVA | Iovance Biotherapeutics, Inc. | 1.42B | -1.71% | 9,267,863 | 263.50M |
| 301 | SVRA | Savara Inc. | 1.41B | 2.20% | 1,203,768 | - |
| 302 | ATRC | AtriCure, Inc. | 1.41B | -0.77% | 548,486 | 534.53M |
| 303 | PGEN | Precigen, Inc. | 1.39B | 1.55% | 5,747,868 | 9.68M |
| 304 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 4.38% | 2,414,236 | 123.67M |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.37B | -2.33% | 918,435 | 2.43B |
| 306 | ATAI | AtaiBeckley Inc. | 1.35B | 4.52% | 2,493,973 | 4.09M |
| 307 | IMTX | Immatics N.V. | 1.34B | 1.73% | 303,161 | 56.67M |
| 308 | BCAX | Bicara Therapeutics Inc. | 1.34B | 3.07% | 678,983 | - |
| 309 | ENOV | Enovis Corporation | 1.34B | 2.73% | 639,036 | 2.25B |
| 310 | PGNY | Progyny, Inc. | 1.32B | -0.71% | 1,006,524 | 1.29B |
| 311 | HROW | Harrow, Inc. | 1.32B | 0.48% | 428,966 | 272.30M |
| 312 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | 1.41% | 1,138,756 | - |
| 313 | NVAX | Novavax, Inc. | 1.31B | -1.47% | 2,792,241 | 1.12B |
| 314 | TNDM | Tandem Diabetes Care, Inc. | 1.29B | -1.88% | 1,870,566 | 1.01B |
| 315 | WVE | Wave Life Sciences Ltd. | 1.29B | -5.79% | 5,381,369 | 42.73M |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.25B | -3.77% | 557,981 | 1.84B |
| 317 | ARDT | Ardent Health, Inc. | 1.24B | 1.29% | 260,313 | 6.32B |
| 318 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -3.58% | 1,652,367 | 9.77M |
| 319 | IRMD | IRADIMED CORPORATION | 1.23B | 0.29% | 68,518 | 83.81M |
| 320 | NVCR | NovoCure Limited | 1.23B | -0.55% | 954,776 | 655.35M |
| 321 | ASTH | Astrana Health, Inc. | 1.21B | -0.04% | 285,410 | 3.18B |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -1.37% | 1,223,211 | - |
| 323 | DBVT | DBV Technologies S.A. | 1.21B | -1.87% | 404,662 | 5.64M |
| 324 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 4.14% | 1,987,486 | 10.00M |
| 325 | MLTX | MoonLake Immunotherapeutics | 1.18B | -11.37% | 4,454,194 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.17B | 0.60% | 494,342 | 83.72M |
| 327 | PHAR | Pharming Group N.V. | 1.16B | 1.68% | 2,470 | 376.13M |
| 328 | ALVO | Alvotech | 1.13B | 5.54% | 473,327 | 588.90M |
| 329 | QDEL | QuidelOrtho Corporation | 1.13B | 0.91% | 2,470,490 | 2.73B |
| 330 | NNNN | Anbio Biotechnology | 1.13B | 0.08% | 37,890 | 6.92M |
| 331 | USPH | U.S. Physical Therapy, Inc. | 1.13B | -0.75% | 106,200 | 773.34M |
| 332 | CNMD | CONMED Corporation | 1.10B | 0.48% | 391,889 | 1.37B |
| 333 | SEPN | Septerna, Inc. | 1.09B | 1.41% | 210,238 | 45.95M |
| 334 | INNV | InnovAge Holding Corp. | 1.09B | - | 251,109 | 915.37M |
| 335 | EYPT | EyePoint, Inc. | 1.09B | 1.01% | 885,070 | 31.37M |
| 336 | AVBP | ArriVent BioPharma, Inc. | 1.07B | 4.98% | 1,041,002 | - |
| 337 | ABCL | AbCellera Biologics Inc. | 1.06B | 0.57% | 1,665,168 | 75.13M |
| 338 | GERN | Geron Corporation | 1.06B | 11.41% | 26,474,061 | 183.88M |
| 339 | PNTG | The Pennant Group, Inc. | 1.06B | -0.43% | 505,677 | 947.71M |
| 340 | QURE | uniQure N.V. | 1.06B | 3.30% | 1,405,640 | 16.10M |
| 341 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 0.54% | 454,011 | 780.57M |
| 342 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 4.14% | 2,314,657 | 291.85M |
| 343 | BFLY | Butterfly Network, Inc. | 1.04B | 1.24% | 3,929,244 | 97.61M |
| 344 | IVA | Inventiva S.A. | 1.01B | -2.16% | 641,553 | 9.31M |
| 345 | KALV | KalVista Pharmaceuticals, Inc. | 1.01B | -1.79% | 1,288,005 | 73.62M |
| 346 | NEO | NeoGenomics, Inc. | 1.01B | 4.45% | 1,770,755 | 727.33M |
| 347 | CTMX | CytomX Therapeutics, Inc. | 985.77M | -2.98% | 5,028,375 | 76.20M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 979.40M | -0.27% | 178,623 | 1.30M |
| 349 | CMPX | Compass Therapeutics, Inc. | 977.88M | 2.65% | 1,912,443 | 850.00K |
| 350 | AZTA | Azenta, Inc. | 975.58M | 0.24% | 988,668 | 595.03M |
| 351 | SSII | SS Innovations International, Inc. | 969.71M | -2.20% | 56,137 | 42.48M |
| 352 | STAA | STAAR Surgical Company | 957.08M | 3.37% | 649,920 | 239.44M |
| 353 | CRON | Cronos Group Inc. | 949.79M | - | 816,307 | 146.59M |
| 354 | AKTS | Aktis Oncology, Inc. | 943.56M | -4.58% | 381,902 | 6.50M |
| 355 | TDOC | Teladoc Health, Inc. | 941.93M | -3.12% | 4,901,148 | 2.53B |
| 356 | BLFS | BioLife Solutions, Inc. | 931.71M | 1.10% | 189,382 | 96.21M |
| 357 | PCRX | Pacira BioSciences, Inc. | 922.76M | 0.84% | 470,247 | 726.41M |
| 358 | URGN | UroGen Pharma Ltd. | 922.04M | 5.34% | 599,906 | 109.79M |
| 359 | XNCR | Xencor, Inc. | 918.93M | 3.90% | 1,029,819 | 125.58M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 918.29M | 3.32% | 677,375 | 719.89M |
| 361 | EVO | Evotec SE | 917.70M | 1.60% | 42,957 | 887.40M |
| 362 | MPLT | MapLight Therapeutics, Inc. | 917.02M | 2.46% | 283,735 | - |
| 363 | CDNA | CareDx, Inc. | 915.24M | 2.94% | 479,550 | 379.81M |
| 364 | GHRS | GH Research PLC | 913.07M | 4.69% | 135,466 | - |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 903.43M | 9.30% | 1,800,156 | 1.02B |
| 366 | CLOV | Clover Health Investments, Corp. | 891.93M | -3.41% | 9,158,338 | 1.92B |
| 367 | FTRE | Fortrea Holdings Inc. | 889.19M | 0.96% | 999,659 | 2.72B |
| 368 | ABUS | Arbutus Biopharma Corporation | 883.56M | 0.44% | 1,197,862 | 14.08M |
| 369 | JANX | Janux Therapeutics, Inc. | 882.67M | 4.39% | 1,029,958 | 10.00M |
| 370 | PHAT | Phathom Pharmaceuticals, Inc. | 877.82M | 0.27% | 944,298 | 175.11M |
| 371 | CERT | Certara, Inc. | 875.27M | -3.51% | 5,832,318 | 418.84M |
| 372 | OMER | Omeros Corporation | 869.71M | 14.39% | 4,637,788 | - |
| 373 | INMD | InMode Ltd. | 868.01M | 0.15% | 682,802 | 370.50M |
| 374 | TALK | Talkspace, Inc. | 862.11M | -0.39% | 1,864,836 | 228.87M |
| 375 | ANNX | Annexon, Inc. | 860.14M | -3.25% | 2,450,620 | - |
| 376 | OPK | OPKO Health, Inc. | 857.75M | -0.88% | 1,613,275 | 606.88M |
| 377 | SDGR | Schrödinger, Inc. | 852.68M | 1.67% | 961,655 | 255.87M |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 843.73M | -1.90% | 669,669 | - |
| 379 | TBPH | Theravance Biopharma, Inc. | 815.65M | -2.40% | 677,047 | 107.46M |
| 380 | SGP | SpyGlass Pharma, Inc. | 814.28M | -5.67% | 88,798 | - |
| 381 | SANA | Sana Biotechnology, Inc. | 813.94M | 5.90% | 3,003,817 | - |
| 382 | EVMN | Evommune, Inc. | 807.53M | -2.48% | 342,498 | 13.00M |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 805.30M | 1.00% | 1,294,543 | 84.28M |
| 384 | TENX | Tenax Therapeutics, Inc. | 804.81M | 0.06% | 557,354 | - |
| 385 | JBIO | Jade Biosciences, Inc. | 790.05M | 14.02% | 2,237,451 | - |
| 386 | BIOA | BioAge Labs, Inc. | 786.85M | 1.37% | 441,624 | 9.00M |
| 387 | MNKD | MannKind Corporation | 782.58M | 3.67% | 3,475,858 | 348.97M |
| 388 | BVS | Bioventus Inc. | 760.87M | 0.22% | 331,522 | 568.09M |
| 389 | SLS | SELLAS Life Sciences Group, Inc. | 756.04M | -0.47% | 4,744,659 | - |
| 390 | ORIC | ORIC Pharmaceuticals, Inc. | 750.18M | -41.00% | 15,619,488 | - |
| 391 | ANRO | Alto Neuroscience, Inc. | 747.84M | 4.14% | 448,951 | - |
| 392 | IART | Integra LifeSciences Holdings Corporation | 745.86M | 1.59% | 927,172 | 1.64B |
| 393 | CSTL | Castle Biosciences, Inc. | 744.77M | 2.04% | 292,857 | 344.23M |
| 394 | RLMD | Relmada Therapeutics, Inc. | 744.72M | 2.01% | 1,738,648 | - |
| 395 | OMDA | Omada Health, Inc. | 743.05M | 0.32% | 669,382 | 260.21M |
| 396 | MGTX | MeiraGTx Holdings plc | 740.35M | 4.97% | 1,165,238 | 81.39M |
| 397 | MRVI | Maravai LifeSciences Holdings, Inc. | 737.78M | 1.41% | 2,213,440 | 185.74M |
| 398 | KURA | Kura Oncology, Inc. | 736.67M | 2.58% | 1,359,881 | 67.48M |
| 399 | SLDB | Solid Biosciences Inc. | 726.13M | 2.50% | 903,439 | - |
| 400 | ARVN | Arvinas, Inc. | 724.68M | 6.89% | 1,974,974 | 262.60M |
| 401 | CMPS | COMPASS Pathways plc | 724.55M | 1.63% | 1,561,680 | - |
| 402 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 722.70M | 0.89% | 325,181 | - |
| 403 | VOR | Vor Biopharma Inc. | 722.03M | -2.52% | 1,563,408 | - |
| 404 | AMN | AMN Healthcare Services, Inc. | 717.46M | 1.20% | 1,023,867 | 2.73B |
| 405 | TLRY | Tilray Brands, Inc. | 715.35M | -5.10% | 5,629,588 | 837.32M |
| 406 | EHAB | Enhabit, Inc. | 708.60M | -0.85% | 1,717,324 | 1.06B |
| 407 | CBLL | CeriBell, Inc. | 696.36M | 0.90% | 290,765 | 89.06M |
| 408 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.84M | 5.13% | 2,904,303 | 49.80M |
| 409 | ETON | Eton Pharmaceuticals, Inc. | 691.93M | 2.76% | 723,688 | 79.95M |
| 410 | DRUG | Bright Minds Biosciences Inc. | 691.10M | -1.71% | 318,112 | - |
| 411 | GDRX | GoodRx Holdings, Inc. | 688.57M | 2.55% | 1,645,426 | 796.85M |
| 412 | PSNL | Personalis, Inc. | 686.38M | 2.98% | 1,220,868 | 69.65M |
| 413 | NUTX | Nutex Health Inc. | 685.96M | 3.58% | 193,654 | 875.26M |
| 414 | DSGN | Design Therapeutics, Inc. | 679.01M | 3.48% | 331,738 | - |
| 415 | ESPR | Esperion Therapeutics, Inc. | 670.28M | -4.74% | 7,138,478 | 403.14M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 660.20M | 3.73% | 68,747 | 116.59M |
| 417 | AVNS | Avanos Medical, Inc. | 655.29M | 0.57% | 415,569 | 701.20M |
| 418 | CBIO | Crescent Biopharma, Inc. | 641.69M | 5.17% | 442,072 | 10.84M |
| 419 | IRWD | Ironwood Pharmaceuticals, Inc. | 635.93M | 11.11% | 2,676,772 | 296.15M |
| 420 | REPL | Replimune Group, Inc. | 628.38M | -0.52% | 1,095,104 | - |
| 421 | LBRX | LB Pharmaceuticals Inc | 627.67M | 0.61% | 199,683 | - |
| 422 | ALLO | Allogene Therapeutics, Inc. | 624.07M | 4.92% | 5,043,512 | 22.00K |
| 423 | DRTS | Alpha Tau Medical Ltd. | 609.03M | -2.12% | 147,370 | - |
| 424 | OCGN | Ocugen, Inc. | 604.84M | -1.10% | 7,315,622 | 4.41M |
| 425 | PRME | Prime Medicine, Inc. | 600.30M | -2.59% | 2,195,971 | 4.63M |
| 426 | HSTM | HealthStream, Inc. | 598.87M | -1.50% | 168,035 | 304.06M |
| 427 | TCMD | Tactile Systems Technology, Inc. | 590.83M | -0.61% | 208,708 | 329.52M |
| 428 | MDXG | MiMedx Group, Inc. | 586.84M | - | 1,456,848 | 418.63M |
| 429 | TECX | Tectonic Therapeutic, Inc. | 577.94M | -0.42% | 158,862 | - |
| 430 | CTKB | Cytek Biosciences, Inc. | 575.90M | 2.52% | 397,740 | 201.49M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 575.44M | 10.40% | 1,403,527 | 7.83M |
| 432 | SIBN | SI-BONE, Inc. | 574.59M | 3.01% | 871,925 | 200.93M |
| 433 | AGMB | AgomAb Therapeutics NV | 574.12M | 12.30% | 549,540 | - |
| 434 | ZURA | Zura Bio Limited | 572.13M | 1.34% | 533,693 | - |
| 435 | VALN | Valneva SE | 569.36M | 0.32% | 274,523 | 205.07M |
| 436 | CRMD | CorMedix Inc. | 554.93M | 3.39% | 1,168,665 | 311.71M |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 552.48M | 0.97% | 539,713 | 106.47M |
| 438 | EIKN | Eikon Therapeutics, Inc. | 544.16M | -4.73% | 230,384 | - |
| 439 | BWAY | BrainsWay Ltd. | 543.19M | 2.18% | 69,984 | 52.23M |
| 440 | PRTA | Prothena Corporation plc | 539.94M | 3.19% | 592,674 | 9.68M |
| 441 | AVR | Anteris Technologies Global Corp. | 531.50M | -4.14% | 1,938,996 | 1.91M |
| 442 | KYTX | Kyverna Therapeutics, Inc. | 530.19M | 1.62% | 825,937 | - |
| 443 | PROK | ProKidney Corp. | 528.35M | -2.23% | 886,809 | 893.00K |
| 444 | EMBC | Embecta Corp. | 520.54M | -0.57% | 990,225 | 1.08B |
| 445 | YDES | YD Bio Limited | 512.63M | -5.32% | 20,351 | 510.36K |
| 446 | PHR | Phreesia, Inc. | 509.59M | 0.24% | 4,303,794 | 480.59M |
| 447 | VTVT | vTv Therapeutics Inc. | 508.54M | 3.33% | 30,294 | 17.00K |
| 448 | RIGL | Rigel Pharmaceuticals, Inc. | 508.01M | 1.70% | 246,670 | 294.28M |
| 449 | UPB | Upstream Bio, Inc. | 506.65M | 3.44% | 848,430 | 2.85M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 504.05M | -0.48% | 937,980 | 44.55M |
| 452 | FDMT | 4D Molecular Therapeutics, Inc. | 503.88M | 6.02% | 686,475 | 85.21M |
| 453 | CATX | Perspective Therapeutics, Inc. | 503.59M | 6.00% | 1,197,016 | 884.00K |
| 454 | CTNM | Contineum Therapeutics, Inc. | 502.17M | 2.99% | 156,309 | - |
| 455 | FULC | Fulcrum Therapeutics, Inc. | 498.17M | -2.48% | 737,641 | 80.00M |
| 456 | ANGO | AngioDynamics, Inc. | 492.14M | 5.01% | 850,153 | 307.31M |
| 457 | VSTM | Verastem, Inc. | 487.48M | 4.72% | 2,926,418 | 30.91M |
| 458 | LRMR | Larimar Therapeutics, Inc. | 486.17M | 4.00% | 1,840,806 | - |
| 459 | TRDA | Entrada Therapeutics, Inc. | 485.28M | 6.81% | 257,054 | 25.42M |
| 460 | LYEL | Lyell Immunopharma, Inc. | 485.02M | 3.74% | 97,677 | 36.00K |
| 461 | ADCT | ADC Therapeutics SA | 482.77M | 1.33% | 744,257 | 81.36M |
| 462 | ABSI | Absci Corporation | 482.02M | 5.00% | 3,232,724 | 2.80M |
| 463 | KMDA | Kamada Ltd. | 475.22M | 1.32% | 49,686 | 180.46M |
| 464 | FLGT | Fulgent Genetics, Inc. | 474.21M | 3.40% | 461,647 | 322.67M |
| 465 | NPCE | NeuroPace, Inc. | 473.69M | 7.00% | 166,853 | 99.99M |
| 466 | ASMB | Assembly Biosciences, Inc. | 466.84M | 6.05% | 77,747 | 72.30M |
| 467 | OFIX | Orthofix Medical Inc. | 466.08M | 1.22% | 317,901 | 822.31M |
| 468 | EPRX | Eupraxia Pharmaceuticals Inc. | 456.57M | 1.24% | 67,992 | - |
| 469 | IMMX | Immix Biopharma, Inc. | 456.55M | -5.38% | 679,837 | - |
| 470 | ENGN | enGene Holdings Inc. | 452.85M | -0.73% | 143,391 | - |
| 471 | AVIR | Atea Pharmaceuticals, Inc. | 450.15M | 5.02% | 625,663 | - |
| 472 | STTK | Shattuck Labs, Inc. | 447.28M | -2.80% | 475,913 | 1.00M |
| 473 | RGNX | REGENXBIO Inc. | 445.42M | 2.98% | 526,022 | 170.44M |
| 474 | VREX | Varex Imaging Corporation | 445.18M | 0.09% | 305,276 | 854.40M |
| 475 | BBNX | Beta Bionics, Inc. | 444.27M | -0.10% | 798,736 | 100.25M |
| 476 | FBRX | Forte Biosciences, Inc. | 443.29M | -4.02% | 342,195 | - |
| 477 | EBS | Emergent BioSolutions Inc. | 432.78M | 0.96% | 912,822 | 742.90M |
| 478 | AURA | Aura Biosciences, Inc. | 429.81M | 0.15% | 294,019 | - |
| 479 | MYGN | Myriad Genetics, Inc. | 429.20M | 2.00% | 853,937 | 824.50M |
| 480 | NAUT | Nautilus Biotechnology, Inc. | 424.62M | -13.53% | 467,908 | - |
| 481 | LXEO | Lexeo Therapeutics, Inc. | 420.07M | -1.22% | 1,144,853 | - |
| 482 | VNDA | Vanda Pharmaceuticals Inc. | 417.89M | 2.32% | 1,087,876 | 216.11M |
| 483 | AUNA | Auna S.A. | 415.95M | 2.00% | 180,200 | 1.30B |
| 484 | STRO | Sutro Biopharma, Inc. | 412.03M | -0.16% | 111,247 | 102.48M |
| 485 | KIDS | OrthoPediatrics Corp. | 411.79M | 2.65% | 91,704 | 236.35M |
| 486 | PACB | Pacific Biosciences of California, Inc. | 407.70M | 2.27% | 8,206,050 | 160.01M |
| 487 | ALT | Altimmune, Inc. | 405.93M | 1.30% | 2,111,437 | 41.00K |
| 488 | CYH | Community Health Systems, Inc. | 397.58M | 1.02% | 1,357,794 | 12.49B |
| 489 | LCTX | Lineage Cell Therapeutics, Inc. | 396.05M | 0.63% | 800,022 | 14.56M |
| 490 | XFOR | X4 Pharmaceuticals, Inc. | 395.50M | 5.33% | 446,548 | 35.11M |
| 491 | DNA | Ginkgo Bioworks Holdings, Inc. | 395.23M | 10.77% | 1,061,999 | 170.16M |
| 492 | NRC | National Research Corporation | 394.42M | 2.12% | 60,207 | 137.39M |
| 493 | XOMA | XOMA Royalty Corporation | 394.05M | 5.42% | 169,809 | 52.15M |
| 494 | IPSC | Century Therapeutics, Inc. | 393.59M | -3.10% | 2,140,032 | 109.16M |
| 495 | RCKT | Rocket Pharmaceuticals, Inc. | 393.02M | 1.12% | 3,553,966 | - |
| 496 | ARMP | Armata Pharmaceuticals, Inc. | 386.84M | 3.13% | 25,916 | 4.90M |
| 497 | AVTX | Avalo Therapeutics, Inc. | 380.57M | 11.86% | 952,018 | 59.00K |
| 498 | NMRA | Neumora Therapeutics, Inc. | 380.47M | 7.18% | 1,622,553 | - |
| 499 | AKBA | Akebia Therapeutics, Inc. | 377.71M | 1.44% | 1,846,874 | 236.20M |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 376.38M | 2.69% | 202,061 | 66.98M |